Clinical Evidence Comparison: What the Trials Reveal
Understanding Wegovy vs Mounjaro Dosage Mechanisms for UK Weight Loss
The fundamental difference between Wegovy vs Mounjaro dosage effectiveness lies in their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones, whilst Mounjaro utilises tirzepatide, a dual GIP and GLP-1 receptor agonist. This mechanistic difference influences how each medication's dosing schedule is designed to optimise weight management outcomes.
Wegovy's dosage escalation follows a precise 5-step protocol over 16 weeks, starting at 0.25mg and reaching the maintenance dose of 2.4mg. Mounjaro employs a 4-dose titration schedule, beginning at 2.5mg and potentially escalating to 15mg for maintenance. Both dosing approaches aim to minimise gastrointestinal side effects whilst maximising therapeutic benefits for weight management.
Wegovy vs Mounjaro Dosage Pricing: Complete UK Cost Breakdown
When evaluating Wegovy vs Mounjaro dosage costs, Wegovy offers transparent pricing with our starter dose at £79.99 for 0.25mg, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the maintenance 2.4mg dose. Our Getting Started bundles provide convenience, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, supporting your initial dosage progression. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25.
The dosage pricing structure reflects the complexity of each pen's formulation and the precise dosing required for safe escalation. Our 3-pen bundles, including the Intro Trio covering 0.25mg, 0.5mg, and 1mg doses for £299.99, provide three months of step-up dosing with Reliable Supply continuity. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to determine which dosing schedule aligns with your clinical needs.
Clinical Trial Evidence: Wegovy Dosage Efficacy in UK Populations
In clinical trials, patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes through the established dosage protocol. The STEP 1 trial demonstrated that the 2.4mg maintenance dose produced approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, as published by Wilding et al. in the New England Journal of Medicine, 2021.
The STEP 5 trial confirmed that Wegovy's dosage schedule maintains efficacy over extended periods, with participants sustaining approximately clinically studied weight loss at 2 years. The SELECT cardiovascular outcomes trial revealed an additional benefit, showing 20% reduction in major cardiovascular events with the established Wegovy dosage regimen, highlighting the medication's comprehensive health impact beyond weight management.
How Wegovy's Dosage Schedule Optimises Weight Management
Wegovy's escalating dosage protocol works by progressively activating GLP-1 receptors in the brain's appetite control centres, promoting satiety after smaller meals and reducing food cravings. The gradual dose increases from 0.25mg to 2.4mg allow your body to adapt to the medication's effects whilst minimising potential gastrointestinal side effects. Each weekly injection delivers consistent semaglutide levels, maintaining appetite regulation throughout the dosing interval. The 4-week intervals between dose escalations provide sufficient time for physiological adaptation whilst ensuring therapeutic progression. This systematic approach to dosing has been specifically designed based on extensive clinical research to optimise both tolerability and weight management effectiveness.
Streamlined Wegovy vs Mounjaro Dosage Assessment Process
Accessing either medication begins with our comprehensive 3-minute online clinical assessment, where you'll provide details about your weight management goals, medical history, and current medications to help determine appropriate dosing. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), evaluating which dosage schedule may be most suitable for your circumstances. Once approved, your chosen medication is dispatched via next-day delivery using our temperature-controlled cold-chain system, ensuring the integrity of your prescription-only medicine. Our ongoing support includes dosage guidance and monitoring throughout your treatment journey. Both medications require regular clinical oversight to ensure safe and effective dosing progression.
Storage and Practical Considerations: Wegovy vs Mounjaro Dosage Management
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, whilst Mounjaro maintains stability for only 21 days under similar conditions. Each Wegovy FlexTouch pen contains 4 doses of your prescribed strength, with clear dosage markings and an intuitive injection mechanism. The medication must be stored at 2-8°C in your refrigerator before first use, making it suitable for most domestic storage situations. The extended room temperature stability makes Wegovy particularly convenient for travel or situations where refrigeration may be temporarily unavailable. Dose escalation cannot be skipped, requiring adherence to the prescribed dosing schedule for optimal safety and efficacy outcomes.
Wegovy vs Mounjaro Dosage Comparison: UK Clinical Approval Status
Both medications have received MHRA approval for weight management in the UK, with distinct dosing protocols reflecting their different mechanisms and clinical development programmes. Wegovy's 5-step dosage escalation has been specifically validated through the comprehensive STEP clinical trial programme, establishing the safety and efficacy profile that supports current UK prescribing guidelines. NICE guidance TA875 recommends Wegovy with specialist weight management support, acknowledging the importance of proper dosing supervision throughout treatment.
The recent MHRA approval of Wegovy 7.2mg as a higher maintenance dose (approved 6 January 2026) demonstrates ongoing development of the dosing options, though this strength is not yet available at EverydayMeds. Both medications are subject to additional monitoring requirements, indicated by the Black Triangle (▼) symbol, emphasising the importance of proper clinical oversight during dosing and treatment progression.
Making Your Wegovy vs Mounjaro Dosage Decision with Expert Support
Your choice between Wegovy and Mounjaro dosing schedules should be guided by clinical factors including your weight management goals, medical history, and tolerance considerations that our experienced prescribers can evaluate during assessment. EverydayMeds' GPhC-registered pharmacy (#9012878) ensures you receive genuine prescription-only medicines with full clinical support throughout your chosen dosing protocol. Start your assessment today using discount code FIRST40 for new customers or DOSE25 for returning customers, with Wegovy available from £79.99 for your initial dose. Our clinical team provides ongoing guidance to ensure your selected dosage schedule delivers optimal results safely and effectively. Remember that both medications work best when combined with a reduced-calorie diet and increased physical activity as part of a comprehensive weight management approach. Begin your clinical assessment today to determine which dosing protocol may be right for your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
